Skip to main navigation
Skip to content
  • Contact
  • Twitter
  • Linkedin
gbt
  • About
    • Our Company
    • Leadership
    • Board of Directors
    • Contact Us
    • Careers
  • Our Commitment
    • Patients & Advocacy
    • GBT’s Supported Conferences
    • COVID-19 Information and Resources
    • Corporate Giving
    • Expanded Access
  • Research
    • Sickle Cell Disease
    • Pipeline
    • Partnerships
    • Publications
  • Our Medicine
  • Investors & Media
    • Company Summary
    • Media Resources
    • Press Releases
    • Events & Presentations
    • Quarterly Results
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Governance
    • Investor FAQs
  • Careers
    • Jobs
  • Contact Us
  • Twitter
  • LinkedIn
Investors & Media
  • Company Summary
  • Media Resources
  • Press Releases
  • Events & Presentations
  • Quarterly Results
  • Analyst Coverage
  • Stock Information
  • SEC Filings
  • Governance
  • Investor FAQs
  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contact

Press Releases

Press Releases

Date Title
Feb 24, 2021
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
Feb 19, 2021
GBT Announces Participation in Upcoming Investor Conferences
Feb 17, 2021
GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
Feb 05, 2021
GBT Announces New Employment Inducement Grants
Feb 04, 2021
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
Jan 27, 2021
European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
Jan 07, 2021
GBT Announces New Employment Inducement Grants
Jan 05, 2021
GBT Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contact
gbt

Copyright 2021
Global Blood Therapeutics, Inc.

  • Privacy Policy
  • Online Tracking Opt-Out Guide
  • Terms of use
  • Community Guidelines

P-VOX-US-00501

  • About
    • Our Company
    • Leadership
    • Board of Directors
    • Contact Us
    • Careers
  • Our Commitment
    • Patients & Advocacy
    • GBT’s Supported Conferences
    • COVID-19 Information and Resources
    • Corporate Giving
    • Expanded Access
  • Research
    • Sickle Cell Disease
    • Pipeline
    • Partnerships
    • Publications
  • Our Medicine
  • Investors & Media
    • Company Summary
    • Media Resources
    • Press Releases
    • Events & Presentations
    • Quarterly Results
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Governance
    • Investor FAQs
  • Careers
    • Jobs
  • Contact Us
  • Twitter
  • LinkedIn
This site uses cookies to give you the best online experience. Learn more, including how to disable certain cookies on our Privacy Page. Accept
Privacy & Cookies Policy